Investment Case

The Case for Upstream
PFAS Destruction

Global PFAS contamination is a crisis measured in trillions of dollars, millions of DALYs, and billions of affected lives. Current approaches focus on downstream cleanup — mopping the floor while the tap runs. This fund targets the source.

5.2M+ Annual DALYs from legacy PFAS across the US, EU, Japan, and China
30 Manufacturing facilities from 12 companies produce the majority of global PFAS
650M+ People exposed through contaminated water in just four regions
0.04% Of contamination sites are manufacturers — but they create 1,000–10,000× higher concentrations

"The math is clear: destroy PFAS at the source."

Dr. Christina Barstow

Environmental engineer with 15+ years of water sector experience and a track record of designing and managing large-scale programs across Africa and Asia.

Credentials

PhD Environmental Engineering, University of Colorado Boulder
  • Former Chief Strategy Officer & COO, Bridges to Prosperity — 175,000+ people reached annually
  • Program Manager, DelAgua Health Rwanda — managed community health workers across 7,500 villages, reaching ~2 million people
  • Mortenson Research Fellow, University of Colorado Boulder
  • Director of Strategic Partnerships, Helvetas USA
883+ citations in peer-reviewed research

Why this matters: Deploying capital into upstream PFAS destruction infrastructure requires someone who combines deep technical water/environmental expertise with a proven ability to manage complex, multi-stakeholder programs at scale. Dr. Barstow's career spans both — from peer-reviewed environmental engineering research to operational leadership of programs reaching millions of people across dozens of countries.

Experience Summary

  • Technical depth: PhD in environmental engineering with research specifically on water treatment, contamination, and public health outcomes
  • Program scale: Managed programs operating across 7,500 villages with thousands of community health workers
  • Strategic leadership: CSO/COO experience at an organization building infrastructure across multiple countries
  • Partnership development: Built and managed strategic partnerships across NGOs, governments, and private sector

What Are PFAS?

Per- and polyfluoroalkyl substances (PFAS) are a class of synthetic chemicals manufactured since the 1940s. Their carbon-fluorine bonds — among the strongest in chemistry — make them virtually indestructible in the environment, earning them the name "forever chemicals."

Scale

4,000–12,000 compounds estimated in commercial use. Only 6 are subject to drinking water regulations. The vast majority remain uncharacterized.

Found In

Non-stick coatings, firefighting foam (AFFF), food packaging, textiles, semiconductors, cosmetics, and thousands of industrial applications.

Health Effects

Kidney & testicular cancer, thyroid disease, immune suppression, reproductive harm, childhood obesity, chronic kidney disease, and more.

Persistence

PFAS do not break down naturally. Global rainwater now exceeds drinking water safety thresholds. They have been detected in Arctic ice cores dating to the 1940s.

Where PFAS Contamination Concentrates

Interactive map of known PFAS manufacturing facilities and regional contamination hotspots. Manufacturing facilities (gold) represent just 0.04% of contamination sites but create concentrations 1,000–10,000× higher than downstream sources.

Legend

PFAS Manufacturer (~30 globally)
Contamination Hotspot
Broader contamination zone

Manufacturing Facilities (Gold Markers)

27 facilities from 12 companies compiled from the following sources:

  • ChemSec SIN List — PFAS manufacturer identification and facility locations
  • Forever Pollution Project — European manufacturing facility mapping (20 active/former EU sites)
  • U.S. EPA PFAS Program — US facility records and enforcement actions
  • Company filings and annual reports (Chemours, Daikin, Solvay/Syensqo, 3M, AGC, Dongyue Group)
  • Lerner, S. (The Intercept) — investigative reporting on Chemours Fayetteville Works, 3M Zwijndrecht

US Contamination Hotspots

European Contamination Hotspots

  • Forever Pollution Project — 22,934 known + 21,426 presumptive sites across 32 countries
  • Le Monde, NDR, WDR, Süddeutsche Zeitung, The Guardian (consortium journalism investigation)
  • Health and Environment Alliance (HEAL) — 12.5 million Europeans with PFAS-polluted drinking water

China Contamination Hotspots

  • Chen, H. et al. (2025), "Spatiotemporal PFAS analysis across 206 Yangtze River sampling points" — meta-analysis of two decades of data
  • Dongjiang River Basin contamination: machine learning analysis (self-organizing maps) of industrial vs. domestic sources
  • Xiaoqing River monitoring data — Shandong Province coastal contamination from fluorochemical manufacturing

Japan Contamination Hotspots

  • Japan Ministry of the Environment — PFOA/PFOS Monitored Substance designation (2020), 50 ppt guideline
  • Settsu City biomonitoring studies — Daikin Yodogawa Plant groundwater (5,500–6,500 ppt), resident blood levels 4.5× national average
  • Yokota Air Base (Tokyo) and Kadena Air Base (Okinawa) AFFF contamination — municipal well shutdowns, Dakujaku River >1,400 ppt PFOS

Methodology Note

Contamination hotspots are displayed as aggregated regional markers (not individual site-level data) to provide a readable overview of contamination concentration patterns. Each marker represents a geographic cluster derived from the source databases listed above. Manufacturing facility coordinates were individually verified against company disclosures and satellite imagery.

Intervene at the Source, Not the Tap

PFAS follow a predictable pathway from manufacturing to human exposure. The further downstream you intervene, the more diffuse the contamination becomes — and the more expensive cleanup gets. Point sources offer concentrated streams at identifiable facilities where destruction technologies can eliminate PFAS before environmental release.

Manufacturing 30 facilities
Industrial Use 20,000+ facilities
🌎 Environment Soil, water, air
💧 Water Supply 100,000+ sites
🏠 Treatment Cannot remove PFAS
🥤 Human Exposure 650M+ people

The leverage point: Consumer products represent millions of diffuse household sources. Atmospheric deposition carries PFAS thousands of kilometers. But manufacturing facilities — just 30 globally — handle PFAS in pure, concentrated forms with contamination levels 1,000–10,000× higher than industrial users. Intervening here prevents contamination across all downstream pathways.

Tier 1: Manufacturers

~30 facilities

12 companies control majority of global PFAS output. Top 3 fluoropolymer producers (Chemours, Daikin, Solvay) hold ~83% market share. These facilities are the origin point for all downstream contamination.

Tier 2: Industrial Users

~20,000 facilities

Metal finishing (~15,000), textiles (~5,000), semiconductors (~1,000), and pulp/paper (~500). Geographically clustered in MI/OH, NC/SC, Bavaria, Shandong. Concentrated wastewater streams enable targeted destruction.

Tier 3: AFFF Stockpiles

Millions of gallons

Military installations, airports, and fire departments store legacy foam awaiting proper disposal. State take-back programs (NH: 10,000+ gallons; OH: 200,000 liters) demonstrate collection is feasible. Industry estimates: 5+ years to eliminate at current capacity.

Quantifying the PFAS Disease Burden

Using population attributable fraction methodology with stratified biomonitoring data, we estimate the annual health burden from legacy PFAS exposure across four key regions. These figures represent only PFOA and PFOS — just 2 of 4,000–12,000 compounds in commerce.

United States
956,340
DALYs / year
83M attributable cases
European Union
507,000
DALYs / year
5.9M attributable cases
China
3,325,366
DALYs / year
200M attributable cases
Japan
414,336
DALYs / year
19.7M attributable cases

Disease Burden by Endpoint — United States

Annual DALYs attributable to legacy PFAS (PFOA/PFOS), by health endpoint

Replacement PFAS: The Growing Threat

RPF-scaled emerging compound burden estimates (US, annual DALYs)

Legacy vs. Emerging Burden

Combined annual DALYs across four regions

Key finding: Replacement PFAS likely generate burden in the millions of DALYs annually, though uncertainty is high. Of the 4,000–12,000 PFAS substances in commerce, only 6 have drinking water regulations. This monitoring gap means the vast majority of health effects remain unquantified while production continues.

The Cost Equation

Downstream PFAS remediation is extraordinarily expensive and often incomplete. Upstream destruction at point sources offers orders-of-magnitude better cost-effectiveness — before contamination disperses into soil, water, and biological systems.

Contamination Sites by Category

US known + presumptive sites by source type

Regional Contamination Scale

Known + presumptive PFAS sites by geography

Proven Approaches to PFAS Destruction

Multiple technologies can achieve >99% destruction of PFAS compounds. The challenge is not technological feasibility — it's deploying capacity at the scale needed to match the contamination.

Supercritical Water Oxidation (SCWO)

Destruction Rate>99.99%
ReadinessCommercial
Best ForHigh-volume streams

Uses water above its critical point (374°C, 221 bar) as a reaction medium. Fast kinetics, complete mineralization. Leading option for concentrated AFFF and industrial wastewater destruction.

Electrochemical Oxidation

Destruction Rate>99%
ReadinessPilot / Early Commercial
Best ForConcentrated streams

Lower energy requirements than thermal methods. No extreme temperature or pressure conditions. Uses boron-doped diamond electrodes to generate reactive species that break C-F bonds.

Plasma-Based Destruction

Destruction Rate>95%
ReadinessPilot
Best ForMixed waste streams

Uses electrical discharges to create plasma that fragments PFAS molecules. Promising for mixed waste matrices. Several companies scaling up pilot systems for field deployment.

Hydrothermal Alkaline Treatment (HALT)

Destruction Rate>99%
ReadinessLab / Pilot
Best ForSolid waste / sludge

Uses subcritical water with sodium hydroxide to defluorinate PFAS through alkaline hydrolysis. Novel approach for PFAS in biosolids, contaminated soil, and solid waste matrices.

Regulatory Tailwinds

Regulation is accelerating globally — creating mandatory demand for destruction capacity. Every new MCL, product ban, and CERCLA designation strengthens the economic case for upstream destruction infrastructure.

2024
EPA finalizes Maximum Contaminant Levels: 4 ppt for PFOA and PFOS — the strictest national standard
Federal — US
2024
EPA designates PFOA and PFOS as CERCLA hazardous substances, enabling Superfund enforcement
Federal — US
2025
Colorado, Maine, Vermont consumer product PFAS bans take effect; Minnesota PFAS in All Products Act effective
State — US
2026
EU ECHA universal PFAS restriction decision expected — covering ~10,000 substances
EU
2027
EPA MCL compliance deadline for large water systems begins
Federal — US
2029
EPA MCL compliance deadline for all remaining water systems
Federal — US
2030
Maine comprehensive ban on all non-essential PFAS uses — first of its kind nationally
State — US
2030
Stockholm Convention global PFAS phase-down targets
International

Investment Approach

The PFAS Destruction Fund deploys capital into upstream destruction infrastructure — targeting the concentrated point sources where intervention offers the highest leverage per dollar deployed.

Target

Upstream PFAS destruction infrastructure at or near manufacturing facilities, major industrial users, and AFFF stockpile locations. Three-tier approach matching intervention to source concentration.

Technologies

Proven destruction methods — supercritical water oxidation and electrochemical oxidation as primary; plasma-based and HALT as emerging. Deployment matched to waste stream characteristics.

Revenue Model

Regulatory compliance fees (EPA MCL deadlines create mandatory demand), avoided liability (CERCLA designation drives proactive destruction), and potential contamination-prevention credit markets.

Impact Metrics

Tonnes of PFAS destroyed, contamination prevented (measured in avoided ppt-volume), communities protected, and DALYs averted through reduced exposure at source.

Fund Design & Scoping

Responses to the Explore Grant framework — presenting the case for a thesis-driven PFAS upstream destruction fund.

About the Applicant

Name
Dr. Christina Barstow
Email
[contact email]

Fund Idea

Title or Focus Area
PFAS Upstream Destruction Fund — deploying capital into point-source destruction infrastructure to eliminate forever chemicals before they enter the environment.
Briefly describe the problem this fund could address
PFAS (per- and polyfluoroalkyl substances) are a class of 4,000–12,000 synthetic compounds that persist indefinitely in the environment. Legacy contamination from just two compounds (PFOA and PFOS) is estimated to cause over 5.2 million DALYs annually across the US, EU, China, and Japan, with attributable health effects including cancer, thyroid disease, obesity, chronic kidney disease, and reproductive harm.

The scale is vast: 2,219 known and 79,891 presumptive contamination sites in the US alone, 44,000+ across Europe, and contamination affecting 400+ million people through just the Yangtze River system in China. An estimated 650+ million people across these four regions have measurable PFAS exposure through drinking water. Only 6 of the thousands of PFAS compounds are subject to drinking water regulation, meaning the true burden is significantly underestimated.

Current approaches focus overwhelmingly on downstream remediation — treating contaminated water, cleaning soil, monitoring exposure. This is necessary but insufficient: it addresses legacy contamination without stopping ongoing production and release. Meanwhile, global PFAS manufacturing continues, with replacement compounds entering the environment in growing volumes. Our analysis estimates replacement PFAS may generate burden in the millions of additional DALYs annually.
Why do you think this is a particularly important or neglected area for philanthropy?
PFAS contamination is a planetary-scale environmental health crisis where the fundamental economics of intervention are dramatically misaligned. Essentially all current spending — regulatory, litigation-driven, and philanthropic — focuses on downstream remediation: water treatment systems, soil cleanup, exposure monitoring, and health studies. This spending is important but operates at enormous cost-per-outcome because contamination has already dispersed across soil, groundwater, surface water, and biological systems.

The neglected opportunity is upstream: the global PFAS production landscape is extraordinarily concentrated. Just 30 manufacturing facilities from 12 companies produce the vast majority of PFAS worldwide. These facilities represent only 0.04% of total contamination sites but exhibit concentrations 1,000–10,000× higher than downstream users. This concentration creates an unusually high-leverage intervention point where relatively modest capital deployment could prevent contamination affecting hundreds of millions of people across all downstream pathways.

Philanthropic attention to PFAS has focused primarily on research, advocacy, and regulatory action — all essential but not addressing the physical destruction of PFAS at source. No existing philanthropic fund targets the deployment of destruction infrastructure at the point sources where PFAS originates.
What's your initial vision for how a fund might create impact here?
The fund would deploy capital across a three-tier point-source hierarchy, matched to source concentration and intervention feasibility:

Tier 1 — Manufacturing facilities (~30 globally): Partner with or incentivize PFAS manufacturers to install destruction technology on production waste streams. These facilities handle PFAS in pure, concentrated forms — ideal for high-efficiency destruction methods like supercritical water oxidation.

Tier 2 — Major industrial users (~20,000 facilities): Target the four primary industrial sectors (metal finishing, textiles, semiconductors, pulp/paper) with sector-specific destruction solutions. Geographic clustering (MI/OH automotive, NC/SC textiles, Shandong Province) enables regional deployment strategies.

Tier 3 — AFFF stockpile destruction: Fund and scale proven collection-and-destruction programs for legacy firefighting foam at military installations, airports, and fire departments. State take-back programs have demonstrated feasibility; this tier offers the most immediately tractable intervention.

The fund could support destruction technology deployment, facility partnerships, regulatory compliance infrastructure, and measurement/verification systems to quantify impact.

Evidence and Rationale

What evidence, data, or reasoning gives you confidence in this idea's potential impact?
Our confidence rests on three empirical foundations:

1. Source concentration is extreme and verified. The Forever Pollution Project (Europe), EWG contamination tracker (US), and academic research (China, Japan) independently confirm that PFAS contamination traces to a small number of identifiable point sources. 3M's Zwijndrecht facility shows 72.8 million ppt — the highest ever measured. Chemours' Washington Works averaged 888× the EPA MCL. Manufacturing facilities create contamination footprints extending hundreds of square kilometers.

2. Health burden is quantifiable and large. Our disease burden model, building on methodology from Obsekov et al. (2022) and a 2026 EU-commissioned study (WSP/Ricardo), estimates legacy PFAS causes 5.2 million DALYs annually across four regions. The US alone: 956,340 DALYs from background cohort exposure. The model uses established exposure-response functions applied across NHANES biomonitoring percentile bins with Levin's attributable fraction formula. Top contributors include osteoporosis (272,000 DALYs), adult obesity (339,000 DALYs), and chronic kidney disease (213,000 DALYs) in the US alone.

3. Destruction technology works. Supercritical water oxidation achieves >99.99% PFAS destruction at commercial scale. Electrochemical oxidation shows >99% at pilot scale. State AFFF take-back programs (NH collected 10,000+ gallons; OH destroying 200,000 liters) demonstrate collection logistics are solvable. The constraint is deployment capital and coordination, not technical feasibility.
Do you have any initial calculations or figures on cost-effectiveness or expected impact?
Health burden addressable:
• Legacy PFAS (all four regions): ~5.2 million DALYs/year (PFOA/PFOS only)
• AFFF-attributable portion: ~780,000 DALYs/year (15% attribution factor)
• Replacement PFAS (central estimate, US only): ~554,000 additional DALYs/year; with unknown compounds factor: ~830,000 DALYs/year
• Combined legacy + emerging (US central estimate): ~1.1 million DALYs/year — and this covers only 7 replacement compounds of thousands in commerce

Source concentration leverage:
• 30 manufacturing facilities = 0.04% of contamination sites but origin of all PFAS
• Top 3 fluoropolymer producers control ~83% of high-purity PFA market
• Asia-Pacific accounts for >52% of PTFE market share (2024)

Rough cost-effectiveness framing:
Using EPA's Value of Statistical Life Year ($200,000/DALY), the monetized annual burden from legacy PFAS alone is approximately $1 trillion across four regions. Preventing even a fraction of replacement PFAS burden through upstream destruction would yield extremely favorable cost-effectiveness ratios relative to downstream remediation, which addresses only legacy contamination at much higher per-unit cost.

Fund Development

If you were to move this idea forward, what approach or steps would you take in the next few months?
1. Technology assessment (Months 1–3): Conduct detailed vetting of destruction technologies — SCWO, electrochemical oxidation, HALT — evaluating technology readiness levels, scalability, cost per kg PFAS destroyed, and effectiveness across different waste stream types and geographic/regulatory contexts.

2. Cost-effectiveness analysis (Months 2–4): Build a rigorous cost-effectiveness model comparing upstream destruction vs. downstream remediation per DALY averted. Incorporate recent analysis suggesting emerging PFAS cleanup costs could substantially exceed legacy remediation costs.

3. Regulatory landscape mapping (Months 1–3): Map how evolving regulatory environments (EPA MCLs, CERCLA designations, EU ECHA restriction, state bans) create enforcement mechanisms and market demand for destruction capacity. Assess existing cleanup efforts such as DOD military site remediation.

4. Legal and financial analysis (Months 3–5): Analyze how ongoing litigation and multi-billion dollar settlements affect the economic case for proactive destruction. Explore funding mechanisms: regulatory compliance revenue, avoided liability pricing, philanthropic capital, and blended finance structures.

5. Stakeholder engagement (Months 2–5): Build relationships with destruction technology companies, PFAS manufacturers, industrial users, military/government waste management, and regulatory bodies to assess partnership structures.
What resources or support would help you move this idea forward?
Funding for 3–5 months of dedicated scoping work, including: technology vendor site visits and due diligence, cost-effectiveness modeling, regulatory analysis across US/EU/Japan/China jurisdictions, legal review of liability and compliance frameworks, and stakeholder relationship development. Access to networks in environmental technology, institutional investors, and regulatory bodies would accelerate the scoping phase. Advisory support from individuals with experience in environmental infrastructure investment, PFAS remediation technology, or fund structuring would be valuable.
Are there individuals who could serve as a potential fund director?
Dr. Christina Barstow would serve as fund director. Her combination of a PhD in environmental engineering (University of Colorado Boulder), 15+ years of water sector experience, and operational leadership of large-scale programs (CSO/COO of Bridges to Prosperity reaching 175,000+ annually; program manager for DelAgua Health Rwanda across 7,500 villages reaching ~2 million people) provides the technical depth and program management experience required to deploy destruction infrastructure at scale.

Scope

Do you have a rough idea of how large in scope you imagine this fund could be?
Initial scoping phase: $5–50K (Explore Grant). Full fund design and pilot: $1–5M. At scale, the fund could deploy $10–20M+ given the size of the addressable problem (monetized burden exceeding $1 trillion annually) and the capital requirements for destruction infrastructure deployment across the three-tier point source hierarchy. The fund could start with the most tractable tier (AFFF stockpile destruction) and scale to industrial and manufacturing source interventions as regulatory demand increases.
Can you share a few illustrative organizations or partners this fund might support?
Destruction technology providers: Companies developing or operating SCWO, electrochemical, and plasma-based PFAS destruction systems at pilot or commercial scale.

AFFF collection programs: State environmental agencies and fire departments operating PFAS foam take-back programs (e.g., New Hampshire, Ohio models) that need destruction capacity funding.

Industrial compliance partners: Metal finishing, textile, and semiconductor facilities facing regulatory deadlines that need destruction infrastructure to meet compliance requirements.

Research institutions: Universities and labs advancing next-generation destruction technologies and monitoring methods for emerging PFAS compounds.

Government/military waste management: DoD and allied military programs managing millions of gallons of legacy AFFF requiring proper destruction rather than indefinite storage.

Sources

  1. PFAS Project Lab, "Known PFAS Contamination Tracker" — pfasproject.com
  2. Environmental Working Group, "PFAS Contamination Map" — ewg.org
  3. Forever Pollution Project, "The Forever Pollution Project" — foreverpollution.eu
  4. U.S. EPA, "PFAS National Primary Drinking Water Regulation" (2024) — epa.gov
  5. WSP/Ricardo (2026), EU-commissioned study on the cost of PFAS pollution in Europe
  6. Obsekov, V. et al. (2022), "Analysis of PFAS health burden in the United States"
  7. Steenland, K. (2018), "Meta-analysis of PFOA and birth weight" (24 studies)
  8. Meng, Q. (2018), "Meta-analysis of PFOS and birth weight"
  9. Liu, G. et al. (2018), "PFAS and childhood obesity" (10 cohorts)
  10. Bartell, S. & Vieira, V. (2021), "PFOA and kidney/testicular cancer meta-analysis"
  11. Du, Y. et al. (2024), "Meta-analysis of PFAS and hypothyroidism"
  12. Pan, Z. et al. (2023), "PFOS and hypertension meta-analysis" (15 studies, n=69,949; Frontiers in Public Health)
  13. Khalil, N. et al. (2016), "PFOA and osteoporosis" (NHANES 2009–2010; EHP 124:81-87)
  14. U.S. Census Bureau, 2023 Population Estimates
  15. CDC NHANES 2017–2020, Serum PFAS biomonitoring data — PMC
  16. EFSA (2020), "Risk to human health related to the presence of perfluoroalkyl substances in food"
  17. OECD, "Global PFAS database and regulatory inventory"
  18. ChemSec, "SIN List — PFAS Manufacturers" — chemsec.org